HSBC initiates Ameren stock with buy rating on data center growth

HSBC initiated coverage of Ameren with a Buy rating and a $119.10 price target, about 12% above the cited $106.48 share price, citing projected 13% rate-base CAGR and 9% EPS growth for 2026–2030. Ameren’s $31.8 billion investment plan for 2026–2030 allocates $21 billion to Missouri; HSBC models 23% load growth by 2031 and 11% adjusted total shareholder return for fiscal 2026–2032. The outlook is tempered by other firms’ lower price targets, an InvestingPro fair-value assessment that the stock appears overvalued, and higher interest rates weighing on utility valuations.

Analysis

The investable question is whether forecast load becomes energized demand soon enough for regulators to let Ameren earn on the associated spend. Contracted capacity is more actionable than pipeline, but neither alone establishes commissioning dates, customer-funded network costs, or timely rate recovery. The key upside mechanism is operating leverage from incremental load on a regulated asset base; the offset is that a large build cycle can widen the gap between cash outlays and recovered revenue, increasing financing and regulatory-lag sensitivity.

The bullish case is unusually exposed to Missouri execution, so consolidated growth forecasts may obscure state-level approval and cost-recovery risk. The expanded gas plan also creates fuel-price, permitting, and emissions-policy exposure alongside the renewables build; this is not a simple “data center equals clean-energy” trade. Higher long-term yields can compress utility multiples while raising the hurdle for a capital-intensive plan. The subordinated-note sale supplies capital, but the proceeds and security structure do not by themselves resolve future funding costs or dilution risk.

Contrarian point: investors may be pricing announced load and planned capex as if both convert directly into earnings. Verify customer energization, signed-load milestones, regulatory treatment, and financing terms. Near term, analyst target dispersion and rate sensitivity may dominate; over 1–3 months, filings and regulatory updates matter more than the headline rating. Over 6–18 months, the thesis depends on load conversion and rate-base additions keeping pace with spending.

Key Decisions for Investors

• Do not chase the coverage upgrade as a standalone catalyst. Keep AEE on a staged-entry watchlist; consider initiating only if long-term yields stabilize and company/regulatory disclosures confirm a credible schedule for energizing contracted large loads and recovering related investment.
• For an existing position, size against a two-sided outcome: upside from load-backed rate-base growth versus multiple compression and cash-flow pressure from capex arriving ahead of recovery. Reassess if Missouri approvals, allowed cost recovery, or load milestones slip.
• Track the next guidance and regulatory disclosures for actual energized load, customer contributions, rate-case timing, capital-spending revisions, and the terms/cost of future financing. A growing pipeline without conversion, or capex rising without matching recovery visibility, would weaken the thesis.
• Falsification triggers: material delays or cancellations in contracted-load commissioning; adverse Missouri cost-recovery decisions; spending materially exceeding the funded/recoverable plan; or a sustained rise in long-term yields that overwhelms earnings delivery. No options position is justified without current implied volatility and catalyst-date data.